Quick Takeaways
- David D. Chang has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $15,472,516.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of David D. Chang
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of David D. Chang is at least $15,472,516 dollars as of 18 Mar 2026. David D. Chang is the President and CEO, Director of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $15.47M.
- Signature
- /s/Earl Douglas, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David D. Chang and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Allogene Therapeutics, Inc. ($15,472,516).
- Past-year value change for that position: -$289,459.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David D. Chang
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | President and CEO, Director | $15,472,516 | -$289,459 | -1.8% | 16 Mar 2026 |
Insider Transactions Reported by David D. Chang:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.